Results 211 to 220 of about 1,208,918 (256)

CFTR Modulators Dampen Aspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes

, 2020
Alexander J. Currie, Ellen T. Main, Heather M. Wilson, Darius Armstrong‐James, Adilia Warris   +4 more
openalex   +1 more source

Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines [PDF]

, 2019
CF Lung Transplant Referral Guidelines Committee,, Dunitz, Jordan M, Faro, Albert, Gray, Alice L, Hempstead, Sarah E, Lucy, Amy, McKone, Edward F, Pilewski, Joseph M, Ramos, Kathleen J, Rosenbluth, Daniel B, Smith, Patrick J, Tallarico, Erin   +11 more
core   +1 more source

Second-Hand Cigarette Smoke Impairs Bacterial Phagocytosis in Macrophages by Modulating CFTR Dependent Lipid-Rafts

, 2015
Inzer Ni, Chang Hoon Ji, Neeraj Vij
openalex   +2 more sources

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. [PDF]

J Fungi (Basel)
Chatterjee P, Moss CT, Omar S, Dhillon E, Hernandez Borges CD, Tang AC, Stevens DA, Hsu JL.   +7 more
europepmc   +1 more source

Innate Immunity in Cystic Fibrosis: Varied Effects of CFTR Modulator Therapy on Cell-to-Cell Communication [PDF]

J. Hynes, Clifford C. Taggart, Rabindra Tirouvanziam, Judith A. Coppinger   +3 more
openalex   +1 more source

Pharmacokinetic variability of CFTR modulators from standard and alternative regimens. [PDF]

Pulm Pharmacol Ther
Rose NR, Chalamalla AR, Garcia BA, Krick S, Bergeron J, Sadeghi H, Schellhase DE, Ryan KJ, Dowell AE, Acosta EP, Guimbellot JS.   +10 more
europepmc   +1 more source

Computational study of the clinical and omic effects of CFTR modulators in cystic fibrosis and search for new targets

, 2022
Matthieu Cornet
openalex   +1 more source

Beyond the 10%: Unraveling the genetic diversity in Turkish cystic fibrosis patients not eligible for CFTR modulators. [PDF]

Pediatr Pulmonol
Yıldız CA, Selçuk Balcı M, Karabulut Ş, Başer ZM, Yüksel Kalyoncu M, Metin Çakar N, Akkitap Yiğit MM, Baysal EE, Özdemircioğlu F, Uzunoğlu B, Taştan G, Ergenekon P, Gökdemir Y, Erdem Eralp E, Karakoç F, Ata P, Karadağ B.   +16 more
europepmc   +1 more source

Lentiviral vector gene therapy and CFTR modulators show comparable effectiveness in cystic fibrosis rat airway models. [PDF]

Gene Ther
McCarron A, Ling KM, Montgomery ST, Martinovich KM, Cmielewski P, Rout-Pitt N, Kicic A, Parsons D, Donnelley M.   +8 more
europepmc   +1 more source

Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators. [PDF]

Pulm Ther
Tomlinson OW, Mitchelmore P, Williams CA.   +2 more
europepmc   +1 more source